Changing Patterns of Causes of Death in Patients With Multiple Myeloma During the Modern Therapeutic Era
BACKGROUND: Therapeutic advances have substantially prolonged survival in multiple myeloma (MM). As survival improves, these findings support integrating cardiovascular care, infection prevention, and long-term management of comorbidities into MM survivorship strategies.
BACKGROUND: Therapeutic advances have substantially prolonged survival in multiple myeloma (MM). As survival improves, these findings support integrating cardiovascular care, infection prevention, and long-term management of comorbidities into MM survivorship strategies.
What the study was
- Study design
- Retrospective cohort study
- Population
- Patients
- Sample size
- 230
- Category
- Prevention
- Maturity
- Exploratory
- Journal
- Clinical lymphoma, myeloma & leukemia
Why it surfaced
Matched Hematologic malignancies; Retrospective cohort study; human study; score 8/10 (n=2 r=3 dq=1 pop=2)
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.